000 | 01884 a2200577 4500 | ||
---|---|---|---|
005 | 20250514042801.0 | ||
264 | 0 | _c20030206 | |
008 | 200302s 0 0 eng d | ||
022 | _a1087-0156 | ||
024 | 7 |
_a10.1038/nbt731 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWeber, Wilfried | |
245 | 0 | 0 |
_aMacrolide-based transgene control in mammalian cells and mice. _h[electronic resource] |
260 |
_bNature biotechnology _cSep 2002 |
||
300 |
_a901-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAlkaline Phosphatase _xgenetics |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
650 | 0 | 4 | _aBase Sequence |
650 | 0 | 4 |
_aCHO Cells _xdrug effects |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 | _aCricetinae |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aEndothelium, Vascular _xdrug effects |
650 | 0 | 4 |
_aErythromycin _xpharmacology |
650 | 0 | 4 |
_aEscherichia coli _xgenetics |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFibroblasts _xdrug effects |
650 | 0 | 4 |
_aFibrosarcoma _xmetabolism |
650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKidney _xembryology |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMolecular Sequence Data |
650 | 0 | 4 |
_aTrans-Activators _xgenetics |
650 | 0 | 4 | _aTransduction, Genetic |
650 | 0 | 4 |
_aTransgenes _xdrug effects |
650 | 0 | 4 |
_aUmbilical Veins _xcytology |
700 | 1 | _aFux, Cornelia | |
700 | 1 | _aDaoud-el Baba, Marie | |
700 | 1 | _aKeller, Bettina | |
700 | 1 | _aWeber, Cornelia C | |
700 | 1 | _aKramer, Beat P | |
700 | 1 | _aHeinzen, Christoph | |
700 | 1 | _aAubel, Dominique | |
700 | 1 | _aBailey, James E | |
700 | 1 | _aFussenegger, Martin | |
773 | 0 |
_tNature biotechnology _gvol. 20 _gno. 9 _gp. 901-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/nbt731 _zAvailable from publisher's website |
999 |
_c12086595 _d12086595 |